Ventricular Fibrillation Epidemiology Forecast 2025-2034

Ventricular Fibrillation Epidemiology Forecast Report Coverage

Expert Market Research's “Ventricular Fibrillation Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of ventricular fibrillation. It projects the future incidence and prevalence rates of ventricular fibrillation cases across various populations. The study covers age, gender, and type as major determinants of the ventricular fibrillation population. The report highlights patterns in the prevalence of ventricular fibrillation over time and projects future trends based on multiple variables.

Ventricular Fibrillation Understanding: Disease Overview

Ventricular fibrillation is a life-threatening heart rhythm disorder, which is often triggered by severe heart conditions, such as myocardial infarction (MI), heart failure, or structural heart abnormalities. The condition is characterized by rapid, irregular electrical activity in the ventricles. Ventricular fibrillation leads to the heart's inability to pump blood effectively, resulting in a loss of circulation. Symptoms of VF include sudden collapse, loss of consciousness, absence of a pulse, and irregular or no breathing.

Ventricular Fibrillation Epidemiology Perspective

The ventricular fibrillation epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for ventricular fibrillation scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for ventricular fibrillation and their trends. The ventricular fibrillation detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• A 2018 review in the Journal of the American College of Cardiology found that 5% to 10% of patients hospitalized with acute myocardial infarction (MI) experience ventricular fibrillation (VF) or ventricular tachycardia (VT), with another 5% developing it within 48 hours.
• The annual incidence of ventricular fibrillation in the pediatric and adolescent age groups is 1.3 to 8.5 cases per 100,000 people.
• With prompt treatment, up to 50% of people can survive ventricular fibrillation. However, without immediate intervention, ventricular fibrillation is fatal. Each minute that passes without defibrillation decreases the chances of survival by 7% to 10%.

Age-Based Ventricular Fibrillation Insights

As per a cohort study of 1,526 patients with ventricular fibrillation and out-of-hospital cardiac arrest published in Resuscitation Journal (2023), the average age was found to be 62, with 29% being women. It was observed that younger women were more likely to survive than younger men (67% vs. 54%). However, survival rates for older women and men were similar (40% vs. 44%).

Gender-Based Ventricular Fibrillation Insights

Data from the FAST-MI registry published in the Journal of the American Heart Association (2022) showed that 359 out of 14,406 patients developed ventricular fibrillation during acute myocardial infarction. It was estimated that men had a slightly higher rate of ventricular fibrillation than women (2.7% vs. 2.0%). Women received fewer cardiac interventions (48.1% vs. 66.9%) and had higher 1-year mortality (50.6% vs. 37.4%).

Country-wise Ventricular Fibrillation Epidemiology Segment

The ventricular fibrillation epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of ventricular fibrillation varies between countries, owing to differences in factors such as the prevalence of coronary artery disease, access to healthcare, lifestyle factors (such as diet, exercise, and smoking rates), genetic predispositions, and availability of defibrillation devices, among others. It is estimated that one-third of the 300,000 cases of sudden cardiac death in the United States are caused by ventricular fibrillation.

Key Questions Answered

• What are the key findings of ventricular fibrillation epidemiology in the 8 major markets?
• What will be the total number of patients with ventricular fibrillation across the 8 major markets during the forecast period?
• What was the country-wise prevalence of ventricular fibrillation in the 8 major markets in the historical period?
• Which country will have the highest number of ventricular fibrillation patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of ventricular fibrillation during the forecast period of 2025-2034?
• What are the currently available treatments for ventricular fibrillation?
• What are the disease risks, signs, symptoms, and unmet needs of ventricular fibrillation?

Related Reports

Neurological Disease Treatment Market Report and Forecast

Ventricular Tachycardia (V-tach or VT) Drug Pipeline Analysis Report